These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7025407)

  • 1. [Immunodiagnosis of lymphoproliferative diseases].
    Hokland P; Ellegaard J
    Ugeskr Laeger; 1981 Apr; 143(15):915-8. PubMed ID: 7025407
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lymphoproliferative disorders].
    Nihon Rinsho; 1990 Jul; 48 Suppl():1064-211. PubMed ID: 2214197
    [No Abstract]   [Full Text] [Related]  

  • 3. Contribution of immunological methods to the diagnosis of hematological malignancies.
    Van Camp B; Potvin P; Jochmans K; Dehou MF; Thielemans K; De Waele M
    Acta Clin Belg; 1987; 42(4):269-73; discussion 273-86. PubMed ID: 2855966
    [No Abstract]   [Full Text] [Related]  

  • 4. [Regulation of growth and development of T-lymphocyte colonies from normal subjects and in lymphoproliferative disorders].
    Shoham D; Goldman J; Radnay J; Gotthelf Y; Katzevman E; Joseph D; Werber MM; Rozenszajn LA
    Harefuah; 1982 Sep; 103(5-6):81-7. PubMed ID: 6984839
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mouse rosettes in the differential diagnosis of lymphoproliferative disorders].
    Gabrielli A; Leoni P; Marchegiani G; Montillo M; Centurioni R; Montroni M; Danieli G
    Minerva Med; 1982 May; 73(20):1383-90. PubMed ID: 7043323
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
    Chloraki-Bobota A; Megalakaki C; Repousis P; Chalkiopoulou I; Lalaki I; Trafalis DT; Athanassiou AE; Mitsouli-Mentzikof C
    J BUON; 2006; 11(4):485-9. PubMed ID: 17309182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The value of cytogenetic, molecular genetic and flow cytometry methods in diagnosis and prognosis of lymphoproliferative diseases after lung transplantation].
    Kandioler D
    Wien Klin Wochenschr; 1993; 105(19):549-55. PubMed ID: 8237020
    [No Abstract]   [Full Text] [Related]  

  • 8. [The characteristics of the clinical course and treatment of chronic obstructive lung diseases against a background of lymphoproliferative diseases].
    Provotorov VM; Kazabtsov AIu
    Ter Arkh; 1997; 69(3):19-23. PubMed ID: 9229820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulopathies associated with lymphoproliferative disorders.
    Boggio L; Green D
    Curr Hematol Rep; 2004 Jan; 3(1):1-4. PubMed ID: 14695843
    [No Abstract]   [Full Text] [Related]  

  • 10. Post-transplant lymphoproliferative disorder mimicking a thrombotic microangiopathy.
    Carrion R; Serrano D; Buño I; Balsalobre P; Gómez-Pineda A; Menárguez J; Muñoz L; Díez-Martín JL
    Biol Blood Marrow Transplant; 2006 Nov; 12(11):1203-5. PubMed ID: 17085315
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diagnosis of lymphoproliferative diseases by bone marrow trepanobiopsy specimens].
    Frank GA; Kaplanskaia IB; Glasko EN; Semenov EA; Roshchina LS; Korolev AV
    Arkh Patol; 2007; 69(3):15-8. PubMed ID: 17722588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver biopsy diagnosis of unsuspected or unconfirmed lymphoproliferative or myeloproliferative disorders.
    Ludwig J; Boon SE
    Hepatogastroenterology; 1980 Feb; 27(1):17-25. PubMed ID: 7203353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Epstein-Barr virus (EBV) serology in lung transplant recipients with primary EBV infection and/or post-transplant lymphoproliferative disease.
    Verschuuren E; van der Bij W; de Boer W; Timens W; Middeldorp J; The TH
    J Med Virol; 2003 Feb; 69(2):258-66. PubMed ID: 12683416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunophenotype analysis in 121 patients with lymphoproliferative diseases by flow cytometry].
    Sun XM; Chen JH; Xu JY; Zhang YF; Xie PH; Fan XN; Xie W
    Ai Zheng; 2004 Aug; 23(8):955-7. PubMed ID: 15301723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic lymphocytic leukemia and related lymphoproliferative disorders.
    Chew T; Amare M
    J Kans Med Soc; 1980 Jan; 81(1):25-8. PubMed ID: 7351506
    [No Abstract]   [Full Text] [Related]  

  • 16. HHV-8+, EBV+ multicentric plasmablastic microlymphoma in an HIV+ Man: the spectrum of HHV-8+ lymphoproliferative disorders expands.
    Seliem RM; Griffith RC; Harris NL; Beheshti J; Schiffman FJ; Longtine J; Kutok J; Ferry JA
    Am J Surg Pathol; 2007 Sep; 31(9):1439-45. PubMed ID: 17721201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoperoxidase study of lymphoreticular lesions.
    Sonakul D; Pacharee P
    J Med Assoc Thai; 1988 Nov; 71(11):605-11. PubMed ID: 3065429
    [No Abstract]   [Full Text] [Related]  

  • 18. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
    Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
    Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new prognosticator for post-transplant lymphoproliferative disorders after renal transplantation.
    Hourigan MJ; Doecke J; Mollee PN; Gill DS; Norris D; Johnson DW; Gandhi MK
    Br J Haematol; 2008 Jun; 141(6):904-7. PubMed ID: 18422782
    [No Abstract]   [Full Text] [Related]  

  • 20. Intracellular defect of neutrophils in patients with cancer.
    Lisiewicz J; Gierek T; Pilch J
    Boll Ist Sieroter Milan; 1979 Jan; 57(6):841-4. PubMed ID: 552829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.